Alex Langford reflects on the findings of a recent study that looks at 185 meta-analyses of antidepressants. It finds that industry involvement in research can lead to biased studies that under-report negative aspects of antidepressants for depression.
[read the full story...]
Mark Horowitz fires up the barbecue and slices some lemons as he summarises a recent meta-analysis which concludes that higher fish consumption was found to be associated with a reduced risk of depression.
[read the full story...]
Amy Price and Douglas Badenoch respond to the McPin Foundation talking point paper written by Alison Faulkner entitled ‘Randomised controlled trials: The straitjacket of mental health research?’
[read the full story...]
Alan Underwood appraises a recent meta-analysis that finds anxiety disorders are three times more common in people with a diagnosis of bipolar disorder.
[read the full story...]
Rosalyn Nelson presents the latest Cochrane systematic review of Rivastigmine for Alzheimer’s disease, which brings together the results of 7 industry sponsored or funded trials, and concludes that Rivastigmine may be of benefit to people with Alzheimer’s disease.
[read the full story...]
Joff Jones highlights an important public health finding from a recent prospective cohort study about the effect of stimulant drugs on the risk of injuries in children with ADHD.
[read the full story...]
Yesterday was #AntiSlaveryDay, so today we are publishing a blog by Mina Fazel who considers the findings of an historical cohort study in the Lancet Psychiatry, which explores the characteristics of trafficked people with severe mental illness.
[read the full story...]
Meg Fluharty summarises a recently updated Cochrane systematic review about interventions for drug-using offenders with co-occurring mental illness.
[read the full story...]
Ioana Cristea considers the impact that researcher allegiance can have on the conducting and reporting of psychotherapy research.
[read the full story...]
Andrew Jones summarises a recent Cochrane systematic review of interventions to increase adherence to smoking cessation medications.
[read the full story...]
